Dana M. Zaher

804 total citations
30 papers, 591 citations indexed

About

Dana M. Zaher is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dana M. Zaher has authored 30 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Dana M. Zaher's work include Cancer, Hypoxia, and Metabolism (6 papers), Synthesis and biological activity (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Dana M. Zaher is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Synthesis and biological activity (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Dana M. Zaher collaborates with scholars based in United Arab Emirates, Egypt and United States. Dana M. Zaher's co-authors include Hany A. Omar, Shifaa M. Abdin, El‐Shaimaa A. Arafa, Fatema Hersi, Mai F. Tolba, Taleb H. Al‐Tel, Sumera Zaib, Jamshed Iqbal, Wael A. A. Fadaly and Mohammed I. El‐Gamal and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Dana M. Zaher

29 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dana M. Zaher United Arab Emirates	17	250	146	121	98	75	30	591
Magdalena Milczarek Poland	20	336 1.3×	148 1.0×	175 1.4×	94 1.0×	98 1.3×	44	947
Linlin Shi China	12	435 1.7×	62 0.4×	113 0.9×	137 1.4×	59 0.8×	21	702
Doretta Cuffaro Italy	15	230 0.9×	142 1.0×	162 1.3×	105 1.1×	40 0.5×	42	541
Ki Deok Shin South Korea	7	404 1.6×	142 1.0×	186 1.5×	64 0.7×	62 0.8×	7	711
Victoria Palau United States	14	459 1.8×	73 0.5×	182 1.5×	144 1.5×	86 1.1×	30	860
Anila Dwivedi India	17	292 1.2×	293 2.0×	137 1.1×	72 0.7×	124 1.7×	41	917
Amr Ahmed El‐Arabey Egypt	13	436 1.7×	90 0.6×	124 1.0×	234 2.4×	152 2.0×	41	811
Rohan J. Meshram India	16	330 1.3×	392 2.7×	96 0.8×	85 0.9×	50 0.7×	48	877
Mayilaadumveettil Nishana India	8	489 2.0×	78 0.5×	78 0.6×	103 1.1×	68 0.9×	12	764
Sonam Mittal India	14	406 1.6×	53 0.4×	81 0.7×	111 1.1×	108 1.4×	28	701

Countries citing papers authored by Dana M. Zaher

Since Specialization

Citations

This map shows the geographic impact of Dana M. Zaher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana M. Zaher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana M. Zaher more than expected).

Fields of papers citing papers by Dana M. Zaher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana M. Zaher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana M. Zaher. The network helps show where Dana M. Zaher may publish in the future.

Co-authorship network of co-authors of Dana M. Zaher

This figure shows the co-authorship network connecting the top 25 collaborators of Dana M. Zaher. A scholar is included among the top collaborators of Dana M. Zaher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana M. Zaher. Dana M. Zaher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abuhelwa, Ahmad Y., Karem H. Alzoubi, Nelson C. Soares, et al.. (2025). Metabolomics insights into doxorubicin and 5-fluorouracil combination therapy in triple-negative breast cancer: a xenograft mouse model study. Frontiers in Molecular Biosciences. 11. 1517289–1517289. 2 indexed citations

Ebrahim, Mohamed, et al.. (2024). Microscopic Colitis Secondary to Leflunomide: A Case Report. Cureus. 16(5). e60064–e60064. 1 indexed citations

Hersi, Fatema, et al.. (2024). Unveiling the therapeutic potential of Taxifolin in Cancer: From molecular mechanisms to immune modulation and synergistic combinations. Phytomedicine. 133. 155934–155934. 7 indexed citations

Zaher, Dana M., et al.. (2024). The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts. Biochemical Pharmacology. 225. 116307–116307. 16 indexed citations

Zaher, Dana M., et al.. (2023). Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells. Life Sciences. 320. 121541–121541. 16 indexed citations

Hersi, Fatema, Anusha Sebastian, Hamadeh Tarazi, et al.. (2023). Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19. European Journal of Medicinal Chemistry. 254. 115380–115380. 14 indexed citations

Hamad, Mohamad, Farah Al‐Marzooq, Vunnam Srinivasulu, et al.. (2022). Antibacterial Activity of Small Molecules Which Eradicate Methicillin-Resistant Staphylococcus aureus Persisters. Frontiers in Microbiology. 13. 823394–823394. 20 indexed citations

Zaher, Dana M., Iman M. Talaat, Amal Hussein, Mahmood Yaseen Hachim, & Hany A. Omar. (2021). Differential expression of pyruvate dehydrogenase E1A and its inactive phosphorylated form among breast cancer subtypes. Life Sciences. 284. 119885–119885. 2 indexed citations

Zaher, Dana M., Wafaa S. Ramadan, Raafat El‐Awady, et al.. (2021). A Novel Benzopyrane Derivative Targeting Cancer Cell Metabolic and Survival Pathways. Cancers. 13(11). 2840–2840. 5 indexed citations

10.

Abdin, Shifaa M., Mai F. Tolba, Dana M. Zaher, & Hany A. Omar. (2021). Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells. Chemico-Biological Interactions. 340. 109450–109450. 52 indexed citations

11.

Zaher, Dana M., et al.. (2021). Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production. Phytomedicine. 83. 153470–153470. 17 indexed citations

12.

Abourehab, Mohammed A. S., Alaa M. Alqahtani, Faisal A. Almalki, et al.. (2021). Pyrrolizine/Indolizine-NSAID Hybrids: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies. Molecules. 26(21). 6582–6582. 11 indexed citations

13.

Zaher, Dana M., et al.. (2020). Recent advances with alkaline phosphatase isoenzymes and their inhibitors. Archiv der Pharmazie. 353(5). e2000011–e2000011. 76 indexed citations

14.

Ramadan, Wafaa S., et al.. (2020). Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance Mechanisms. International Journal of Molecular Sciences. 21(2). 565–565. 16 indexed citations

15.

Zaraei, Seyed–Omar, Mohammed I. El–Gamal, Hanan S. Anbar, et al.. (2020). Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells. European Journal of Medicinal Chemistry. 210. 113081–113081. 17 indexed citations

16.

El-Menshawe, Shahira F., et al.. (2020). The use of new quinazolinone derivative and doxorubicin loaded solid lipid nanoparticles in reversing drug resistance in experimental cancer cell lines: A systematic study. Journal of Drug Delivery Science and Technology. 56. 101569–101569. 10 indexed citations

17.

El–Gamal, Mohammed I., Saif Ullah, Seyed–Omar Zaraei, et al.. (2019). Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase. European Journal of Medicinal Chemistry. 181. 111560–111560. 25 indexed citations

18.

Abdellatif, Khaled R.A., Wael A. A. Fadaly, Yaser A. Mostafa, Dana M. Zaher, & Hany A. Omar. (2019). Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities. Bioorganic Chemistry. 91. 103132–103132. 51 indexed citations

19.

Zaher, Dana M. & Hany A. Omar. (2018). Energy restriction as a novel approach targeting breast cancer stem cells multi-drug resistance. Annals of Oncology. 29. iii20–iii21. 1 indexed citations

20.

Omar, Hany A., Dana M. Zaher, Vunnam Srinivasulu, et al.. (2017). Design, synthesis and biological evaluation of new pyrrolidine carboxamide analogues as potential chemotherapeutic agents for hepatocellular carcinoma. European Journal of Medicinal Chemistry. 139. 804–814. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact